ACC 2019: 12-month results show ticagrelor safe in STEMI patients treated with thrombolysis
ACC 2019: Use of guideline-directed medical therapies for comorbidities may improve outcomes for patients with atrial fibrillation
Although nearly two-thirds of the study population did not receive all the guideline-directed medical therapies for which they were eligible, use of all therapies was linked to better outcomes in s
ACC 2019: Some heart disease, AF patients on combined therapies could skip aspirin
Data show bleeding risk from aspirin could outweigh protection from another heart event.
ACC 2019: Study confirms diagnostic accuracy of non-invasive technology for heart pain
Compound improves heart failure biomarker even after hospitalization
A new study shows sacubitril/valsartan can still improve heart stress if prescribed later.
ACC 2019: A multidisciplinary approach to improve care for geriatric heart failure patients
Care for older adults with heart failure can be optimized using a four-domain framework including medical, mind, physical function, and social environment.
ACC 2019: Disparities persist in treatment of symptomatic aortic valve stenosis
New research shows that although racial disparities have diminished in recent years, gender disparities are still common.
ACC 2019: Oral anticoagulants underused, aspirin overused to treat atrial fibrillation in patients with advanced chronic kidney disease
ACC 2019: Benefits and drawbacks of high-sensitivity troponin use in low-risk patients with chest pain
Few treatment guidelines for heart disease are based on rigorous study
More than 90 percent of heart care recommendations are supported by lower-quality evidence, a new study finds.